A $4 billion market growing at 12% annually, with 800+ licensed manufacturers and rising export demand. CZAAH facilitates market entry, manufacturing partnerships, and regulatory navigation for international pharmaceutical investors.
Explore Partnerships →Pakistan's pharmaceutical manufacturing covers a comprehensive range of products — from high-volume generics to precision surgical instruments.
Pakistan's pharmaceutical regulatory framework aligned with international standards across manufacturing, quality, and product certification.
| Certification | Governing Body | Status | Coverage |
|---|---|---|---|
| WHO GMP | DRAP | Active | 400+ certified facilities |
| ISO 9001:2015 | PSQCA | Active | Standard for all manufacturers |
| EU GMP | EMA via DRAP | In Progress | 15+ facilities certified |
| US FDA Registration | FDA | Active | 25+ registered facilities |
| CE Marking | EU Notified Bodies | Active | Surgical instruments (Sialkot) |
| ISO 13485 | Medical Devices | Active | 500+ manufacturers |
| Halal Certification | SANHA / JAKIM | Active | Growing adoption |
| WHO Prequalification | WHO | In Progress | Vaccines & APIs |
Pharmaceutical market entry and partnership facilitation across Pakistan's growing healthcare sector.
Sector analysis, regulatory landscape mapping, and strategic guidance for pharmaceutical companies evaluating Pakistan.
Connection with licensed Pakistani manufacturers for contract manufacturing, toll manufacturing, and joint venture production facilities.
DRAP (Drug Regulatory Authority of Pakistan) registration, product licensing, GMP compliance, and import/export permits.
Distribution network access, cold chain logistics, and hospital/pharmacy channel partnerships across Pakistan's 230M+ consumer market.
Access to Pakistan's growing Active Pharmaceutical Ingredient production capabilities and raw material sourcing networks.
International registration support and connection with buyers in Gulf, African, and Central Asian markets through our international trading network.
High-growth segments within Pakistan's pharmaceutical and healthcare landscape.
Pakistan's generic drug market is rapidly expanding. Growing domestic demand and export opportunities to underserved markets create strong investment cases.
Hospitals, diagnostic centres, and medical supply chains are severely underdeveloped relative to population. Private investment is being actively encouraged.
Growing global demand for halal-certified medicines positions Pakistan as a natural manufacturing hub for Gulf and Southeast Asian markets.
Government incentives for biotechnology research and pharmaceutical R&D are creating opportunities for technology-forward investors.
Market entry, manufacturing partnerships, and regulatory navigation for pharmaceutical and healthcare investors.
Discuss Market Entry →